This FDA funding opportunity focuses on identifying drug-related and formulation-related factors that cause alcohol dose dumping in modified release oral drug products. The grant does not permit clinical trials and lacks detailed eligibility or description information. The deadline is May 19, 2026.
Eligibility details not specified in the grant listing. Contact the funding organization for requirements.
